AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Whitehawk Therapeutics, Inc. Director's Dealing 2021

Oct 25, 2021

34276_dirs_2021-10-25_27278152-21a0-41a6-aeb6-e8e5c3e2c52e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aadi Bioscience, Inc. (AADI)
CIK: 0001422142
Period of Report: 2021-10-21

Reporting Person: ITRI LORETTTA M (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3000	Indirect